Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters

被引:30
|
作者
Chace, Donald H. [1 ]
Lim, Timothy [2 ]
Hansen, Christina R. [1 ]
De Jesus, Victor R. [2 ]
Hannon, W. Harry [2 ]
机构
[1] Pediatrix Med Grp Inc, Pediatrix Analyt, Ctr Res & Educ, Sunrise, FL 33323 USA
[2] Ctr Dis Control & Prevent, Newborn Screening Qual Assurance Program, Atlanta, GA 30341 USA
关键词
Tandem mass spectrometry; Succinylacetone; Acylcarnitines; Tyrosinemia type 1; Dried blood spots; Newborn screening; TANDEM MASS-SPECTROMETRY; TYROSINEMIA TYPE-I; HEPATORENAL TYROSINEMIA; HEREDITARY TYROSINEMIA; SPECIMENS; URINE; QUANTIFICATION; INFANTS;
D O I
10.1016/j.cca.2009.06.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The utilization of succinylacetone (SUAC) as the primary metabolic marker for tyrosinemia Type 1 is now well known. thus new methods have been developed to analyze SUAC as a first tier test in newborn screening. One approach is to prepare a SUAC hydrazine derivative from the dried blood spots (DBS) previously utilized in the extraction of acylcarnitine (AC) and amino acids (AA). The final derivatized products of SUAC, AA and AC are combined in a single tandem mass spectrometric (MS/MS) analysis. However, butyl esterification techniques may result in contamination of underivatized acylcarnitines by as much as 20%. We have developed a simple wash step to improve the combined analysis of SUAC, AA and AC in DBS by MS/MS. Methods: AA and AC were extracted with methanol containing labeled internal standard from 3.2 mm punches taken from the DBS specimen. The previously extracted blood spot that remains after removal of the methanol extraction solvent was used in the preparation of SUAC with and without additional washing of the blood spot. The butyl ester eluates of AA and AC, and SUAC hydrazine derivatives were recombined and measured by MS/MS. Results: Three additional methanol wash steps of the remaining DBS punches prior to SUAC derivatization reduced the presence of underivatized acylcarnitines, resulting in a 4-fold reduction of underivatized palmitoylcarnitine. Palmitoylcarnitine butyl ester is detected at m/z 456 while the underivatized species is detected at m/z 400, which is also the mass of dodecanoylcarnitine butyl ester. The linearity of the SUAC assay was unchanged by the additional wash steps. For butyl esterification methods, the preferred analytic procedure, the presence of AC can compromise the results of a newborn screen for the actual concentrations of acylcarnitines. It is essential to remove any underivatized acylcarnitines prior to SUAC analysis. Conclusion: The additional methanol wash steps did not alter SUAC assay results but did remove underivatized acylcarnitines which could result in the incorrect quantification of acylcarnitines. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 44 条
  • [21] Analysis of 2-methylcitric acid, methylmalonic acid, and total homocysteine in dried blood spots by LC-MS/MS for application in the newborn screening laboratory: A dual derivatization approach
    Dubland, Joshua A.
    Rakic, Bojana
    Vallance, Hilary
    Sinclair, Graham
    JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB, 2021, 20 : 1 - 10
  • [22] Determination of fatty acid ethyl esters in dried blood spots by LC–MS/MS as markers for ethanol intake: application in a drinking study
    Marc Luginbühl
    Alexandra Schröck
    Stefan König
    Stefan Schürch
    Wolfgang Weinmann
    Analytical and Bioanalytical Chemistry, 2016, 408 : 3503 - 3509
  • [23] Determination of fatty acid ethyl esters in dried blood spots by LC-MS/MS as markers for ethanol intake: application in a drinking study
    Luginbuehl, Marc
    Schroeck, Alexandra
    Koenig, Stefan
    Schuerch, Stefan
    Weinmann, Wolfgang
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2016, 408 (13) : 3503 - 3509
  • [24] Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening
    Monostori, Peter
    Szabo, Pal
    Marginean, Otilia
    Bereczki, Csaba
    Karg, Eszter
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 84 (05): : 311 - 318
  • [25] ESI-MS/MS measurement of free carnitine and its precursor γ-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders
    Primassin, Sonja
    Spiekerkoetter, Ute
    MOLECULAR GENETICS AND METABOLISM, 2010, 101 (2-3) : 141 - 145
  • [26] Semi-quantitative measurement of the antimalarial lumefantrine from untreated dried blood spots using LC-MS/MS
    Ippolito, Matthew M.
    Huang, Liusheng
    Siame, Mwiche
    Thuma, Philip
    Shapiro, Theresa A.
    Aweeka, Francesca T.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 155 : 241 - 246
  • [27] High resolution mass spectrometry newborn screening applications for quantitative analysis of amino acids and acylcarnitines from dried blood spots
    Pickens, C. Austin
    Petritis, Konstantinos
    ANALYTICA CHIMICA ACTA, 2020, 1120 : 85 - 96
  • [28] Steroid profiling by UHPLC-MS/MS in dried blood spots collected from healthy women with and without testosterone gel administration
    Salamin, Olivier
    Nicoli, Raul
    Xu, Cheng
    Boccard, Julien
    Rudaz, Serge
    Pitteloud, Nelly
    Saugy, Martial
    Kuuranne, Tiia
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 204
  • [29] Expanding the knowledge on dried blood spots and LC-MS-based protein analysis: two different sampling materials and six protein targets
    Rosting, Cecilie
    Gjelstad, Astrid
    Halvorsen, Trine Gronhaug
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2017, 409 (13) : 3383 - 3392
  • [30] LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation
    Gallay, Joanna
    Prod'hom, Sylvain
    Mercier, Thomas
    Bardinet, Carine
    Spaggiari, Dany
    Pothin, Emilie
    Buclin, Thierry
    Genton, Blaise
    Decosterd, Laurent Arthur
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 154 : 263 - 277